SEC Form 4 · accession 0001628656-17-000006
MYRIAD GENETICS INC · MYGN
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Bernard Tobin
Officer — President Crescendo BioScience
Period of report
Sep 30, 2017
Accepted (ET)
Oct 3, 2017 · 5:20 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000899923
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Sep 30, 2017 | D | 6,472 | $36.18 | D | 151,390 | D | |
| Common Stock | Sep 30, 2017 | D | 5,218 | $36.18 | D | 146,172 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Represents shares withheld by the Company to satisfy tax withholding obligations in connection with the vesting of performance stock units granted to the reporting person.
- F2Represents shares withheld by the Company to satisfy tax withholding obligations in connection with the vesting of restricted stock units granted to the reporting person.